MX2022007009A - Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion. - Google Patents
Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion.Info
- Publication number
- MX2022007009A MX2022007009A MX2022007009A MX2022007009A MX2022007009A MX 2022007009 A MX2022007009 A MX 2022007009A MX 2022007009 A MX2022007009 A MX 2022007009A MX 2022007009 A MX2022007009 A MX 2022007009A MX 2022007009 A MX2022007009 A MX 2022007009A
- Authority
- MX
- Mexico
- Prior art keywords
- topical composition
- composition
- cooling
- abaility
- measuring
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/417—Imidazole-alkylamines, e.g. histamine, phentolamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/56—Investigating or analyzing materials by the use of thermal means by investigating moisture content
- G01N25/58—Investigating or analyzing materials by the use of thermal means by investigating moisture content by measuring changes of properties of the material due to heat, cold or expansion
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Reproductive Health (AREA)
- Gynecology & Obstetrics (AREA)
- Biochemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pathology (AREA)
- Physics & Mathematics (AREA)
- Immunology (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Endocrinology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Urology & Nephrology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Combustion & Propulsion (AREA)
- Inorganic Chemistry (AREA)
- Dermatology (AREA)
- Vascular Medicine (AREA)
- Surgery (AREA)
- Heart & Thoracic Surgery (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Se proporciona una composición para aplicación tópica en el pene para el tratamiento de la disfunción eréctil, la composición está libre de trinitrato de glicerilo (GTN), sildenafilo y un inhibidor de la acetilcolinesterasa, y comprende disolventes volátiles y no volátiles, comprendiendo los disolventes volátiles un alcohol inferior y agua. y los disolventes no volátiles que comprenden un alcohol polihídrico y un glicol; preferiblemente, la composición no contiene ningún ingrediente farmacéuticamente activo para el tratamiento de la disfunción eréctil; también se proporciona un método para determinar la capacidad de enfriamiento de una composición de prueba, tal como la composición descrita anteriormente.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1918039.7A GB201918039D0 (en) | 2019-12-09 | 2019-12-09 | Topical composition |
GBGB2015404.3A GB202015404D0 (en) | 2020-09-29 | 2020-09-29 | Topical composition |
PCT/GB2020/052660 WO2021116651A1 (en) | 2019-12-09 | 2020-10-22 | Topical composition and methods of measuring the cooling abaility of a topical composition |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2022007009A true MX2022007009A (es) | 2022-08-25 |
Family
ID=73040144
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2022007009A MX2022007009A (es) | 2019-12-09 | 2020-10-22 | Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion. |
Country Status (13)
Country | Link |
---|---|
US (1) | US20230022570A1 (es) |
EP (2) | EP4342494A3 (es) |
KR (1) | KR20220124712A (es) |
CN (1) | CN115003278A (es) |
AU (1) | AU2020401440A1 (es) |
BR (1) | BR112022011284A2 (es) |
CA (1) | CA3160206A1 (es) |
DK (1) | DK3934624T3 (es) |
FI (1) | FI3934624T3 (es) |
MX (1) | MX2022007009A (es) |
PT (1) | PT3934624T (es) |
TW (1) | TW202135785A (es) |
WO (1) | WO2021116651A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN117618335A (zh) * | 2023-12-27 | 2024-03-01 | 江苏邦赛药业有限公司 | 一种功能凝胶及其制备方法与应用 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2716739B2 (ja) * | 1988-07-26 | 1998-02-18 | インデナ エス.ピー.エイ | 血管運動作用を有する化粧用組成物 |
US5093133A (en) * | 1990-01-24 | 1992-03-03 | Mcneil-Ppc, Inc. | Method for percutaneous delivery of ibuprofen using hydroalcoholic gel |
US5942545A (en) * | 1998-06-15 | 1999-08-24 | Macrochem Corporation | Composition and method for treating penile erectile dysfunction |
US6435710B1 (en) * | 1998-08-26 | 2002-08-20 | Fauske & Associates, Inc. | Foam detector apparatus and method |
GB0602224D0 (en) * | 2006-02-03 | 2006-03-15 | Futura Medical Dev Ltd | Composition for promoting vascular smooth muscle relaxation |
RU2342923C1 (ru) * | 2007-07-26 | 2009-01-10 | Общество с ограниченной ответственностью "Бентус лаборатории" | Дезинфицирующее антисептическое средство для обработки рук с увлажняющим эффектом (варианты) |
US20090318510A1 (en) * | 2008-06-24 | 2009-12-24 | Glycobiosciences, Inc. | Topical drug delivery system |
WO2010044094A2 (en) | 2008-09-03 | 2010-04-22 | Krishna Radharaman Agarwal | A topical composition for the treatment of erectile dysfunction |
US20140227342A1 (en) | 2013-02-08 | 2014-08-14 | Michael Farber | Acetylcholinesterase inhibitor composition for sexual use |
MX2016013826A (es) * | 2014-04-21 | 2017-07-28 | Aclaris Therapeutics Inc | Formulaciones de peroxido y metodos y aplicaciones para utilizarlas. |
GB201609968D0 (en) * | 2016-06-07 | 2016-07-20 | Futura Medical Dev Ltd | Topical pharmaceutical formulation |
GB201713160D0 (en) | 2017-08-16 | 2017-09-27 | Futura Medical Dev Ltd | Topical composition |
WO2019229535A2 (en) * | 2018-06-01 | 2019-12-05 | Druggability Technologies Ip Holdco Ltd. | Topical amlodipine salts for the treatment of anorectal diseases |
-
2020
- 2020-10-22 CA CA3160206A patent/CA3160206A1/en active Pending
- 2020-10-22 FI FIEP20800255.0T patent/FI3934624T3/fi active
- 2020-10-22 KR KR1020227023539A patent/KR20220124712A/ko unknown
- 2020-10-22 BR BR112022011284A patent/BR112022011284A2/pt unknown
- 2020-10-22 EP EP24155635.6A patent/EP4342494A3/en active Pending
- 2020-10-22 MX MX2022007009A patent/MX2022007009A/es unknown
- 2020-10-22 WO PCT/GB2020/052660 patent/WO2021116651A1/en unknown
- 2020-10-22 US US17/783,873 patent/US20230022570A1/en active Pending
- 2020-10-22 PT PT208002550T patent/PT3934624T/pt unknown
- 2020-10-22 EP EP20800255.0A patent/EP3934624B1/en active Active
- 2020-10-22 AU AU2020401440A patent/AU2020401440A1/en active Pending
- 2020-10-22 DK DK20800255.0T patent/DK3934624T3/da active
- 2020-10-22 CN CN202080085526.8A patent/CN115003278A/zh active Pending
- 2020-12-08 TW TW109143296A patent/TW202135785A/zh unknown
Also Published As
Publication number | Publication date |
---|---|
DK3934624T3 (da) | 2024-06-10 |
FI3934624T3 (fi) | 2024-05-24 |
CA3160206A1 (en) | 2021-06-17 |
US20230022570A1 (en) | 2023-01-26 |
AU2020401440A1 (en) | 2022-06-16 |
EP4342494A2 (en) | 2024-03-27 |
EP3934624B1 (en) | 2024-03-13 |
WO2021116651A1 (en) | 2021-06-17 |
EP4342494A3 (en) | 2024-06-05 |
PT3934624T (pt) | 2024-04-23 |
KR20220124712A (ko) | 2022-09-14 |
TW202135785A (zh) | 2021-10-01 |
EP3934624A1 (en) | 2022-01-12 |
CN115003278A (zh) | 2022-09-02 |
BR112022011284A2 (pt) | 2022-09-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2017003445A1 (es) | Formas solidas y formulaciones de compuestos de imidazopirazina. | |
EA201500432A1 (ru) | Соединения боронатного эфира и его фармацевтические составы | |
EA200400966A1 (ru) | Новые лекарственные формы замещенного бензимидазола и способ их применения | |
BRPI0510719A (pt) | derivados de naftalimida, composição farmacêutica, uso e método de preparação dos mesmos | |
MXPA05008838A (es) | Formulaciones de absorcion acelerada del agonista selectivo de la 5-ht. | |
MX2020009235A (es) | Formulacion oftalmica. | |
EA200870526A1 (ru) | Композиция, включающая по меньшей мере один высший алифатический спирт и экстракт griffonia simplicifolia | |
PH12016502100A1 (en) | Liquid formulation comprising gm-csf neutralizing compound | |
MX2023002324A (es) | Tratamiento de trastornos de perdida de cabello con inhibidores de cinasas asociadas a janus (jak) deuterados. | |
MX2022007009A (es) | Composicion topica y metodos de medicion de la capacidad de refrigeracion de una composicion. | |
EA202190261A1 (ru) | Топические маслянистые композиции | |
EE05344B1 (et) | Ühendi (deaminohüdroksü)toremifeeni kasutamine tupekuivuse v?i seksuaaldüsfunktsiooni ravis menopausi ajal v?i järel | |
EA201992090A1 (ru) | ДЕЙТЕРИРОВАННЫЕ СОЕДИНЕНИЯ ИМИДАЗО[4,5-c]ХИНОЛИН-2-ОНА И ИХ ПРИМЕНЕНИЕ В ЛЕЧЕНИИ РАКА | |
DE60141274D1 (de) | Kombinationstherapie zur behandlung respiratorischer krankheiten mittels antikörper und anti-entzündungs wirkstoffe | |
MX2015017879A (es) | Derivados de estratrientiazol 17-nitrogeno substitutidos terapeuticamente activos como inhibidores de 17.beta-hidroxiestero ide deshidrogenasa. | |
EA202192322A1 (ru) | Фармацевтические составы | |
EA200501166A1 (ru) | Составы и способы лечения тромбоцитемии | |
DK1414467T3 (da) | Topisk behandling af mastalgi | |
DK1638582T3 (da) | Anvendelse af hyaluronsyre til fremstilling af kompositioner til behandling af tilbagevendende after | |
MX2023007091A (es) | Composiciones oftalmicas que contienen una prostamida liberadora de oxido nitrico. | |
EA201992826A1 (ru) | 15бета-[3-пропанамидо]-замещенные эстра-1,3,5(10)-триен-17-оны и их 17-оксимы для применения в ингибировании 17бета-гидроксистероиддегидрогеназ | |
ATE344025T1 (de) | Behandlung oder prävention von urogenitaler atrophie und deren symptomen bei frauen | |
MX2020002336A (es) | Composicion lipolitica que contiene derivados de fosfocolina. | |
MX2022010800A (es) | Composiciones y metodos para la administracion de naloxona. | |
AU2021300281A8 (en) | RORγt inhibitors and topical uses thereof |